UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 262

Sortiert nach

Trimodality therapy for malignant pleural mesothelioma: results from an EORTC phase II multicentre trial

The European respiratory journal, 2010-12, Vol.36 (6), p.1362-1369

2010

Volltextzugriff (PDF)

Prophylactic antineoplastic activity of Toxoplasma gondii RH derived antigen against ehrlich solid carcinoma with evidence of shared antigens by comparative immunoblotting

Infectious agents and cancer, 2023-04, Vol.18 (1), p.21-21, Article 21

2023

Volltextzugriff (PDF)

Is a patient's self-reported health-related quality of life a prognostic factor for survival in non-small-cell lung cancer patients? A multivariate analysis of prognostic factors of EORTC study 08975

Annals of oncology, 2006-11, Vol.17 (11), p.1698-1704

2006

Volltextzugriff (PDF)

Real-world Treatment Patterns and Outcomes in Stage III Non-small Cell Lung Cancer: Middle East and Africa – KINDLE Study

Clinical lung cancer, 2022-06, Vol.23 (4), p.364-373

2022

Volltextzugriff (PDF)

Evaluation of ImmunoCard STAT test and ELISA versus light microscopy in diagnosis of giardiasis and cryptosporidiosis

Parasitology research (1987), 2015-08, Vol.114 (8), p.2853-2863

2015

Volltextzugriff (PDF)

Afatinib in chemotherapy pre-treated EGFR mutation-positive NSCLC

Annals of oncology, 2018-11, Vol.29, p.ix146-ix146

2018

Volltextzugriff (PDF)

162P Molecular markers in advanced non small cell lung cancer patients receiving gemcitabine & cisplatin

Journal of thoracic oncology, 2016-04, Vol.11 (4), p.S128-S128

2016

Volltextzugriff (PDF)

Chitosan and silver nanoparticles: Promising anti-toxoplasma agents

Experimental parasitology, 2014-08, Vol.143, p.30-38

2014

Volltextzugriff (PDF)

Molecular marker analysis of heading date Hd1 locus in Egyptian rice varieties

African journal of biotechnology, 2010-06, Vol.9 (23), p.3368-3372

Gaafar, R M

2010

Volltextzugriff (PDF)

Toxoplasma gondii-derived antigen modifies tumor microenvironment of Ehrlich solid carcinoma murine model and enhances immunotherapeutic activity of cyclophosphamide

Medical oncology (Northwood, London, England), 2023-04, Vol.40 (5), p.136-136, Article 136

2023

Volltextzugriff (PDF)

Epidemic of mesothelioma in Egypt

Lung cancer, 2005-07, Vol.49, p.S17-S20

2005

Volltextzugriff (PDF)

Prognostic effect of drug resistance of glutathione-S-transferase in non small lung cancer

Lung cancer (Amsterdam, Netherlands), 2012-06, Vol.77, p.S21-S21

2012

Volltextzugriff (PDF)

Effect of alginate nanoparticles on the immunogenicity of excretory-secretory antigens against acute toxoplasmosis in murine model

Acta tropica, 2022-01, Vol.225, p.106215-106215, Article 106215

2022

Volltextzugriff (PDF)

3099 Phase 3 trial (NGR015) of best investigator choice (BIC) with or without NGR-hTNF in previously treated malignant pleural mesothelioma (MPM)

European journal of cancer (1990), 2015-09, Vol.51, p.S634-S634

2015

Volltextzugriff (PDF)

Evaluation of enzyme immunoassay techniques for diagnosis of the most common intestinal protozoa in fecal samples

International journal of infectious diseases, 2011-08, Vol.15 (8), p.e541-e544

Gaafar, Maha R

2011

Volltextzugriff (PDF)

A prognostic index for progression-free survival in malignant mesothelioma with application to the design of phase II trials: A combined analysis of 10 EORTC trials

European journal of cancer (1990), 2009-09, Vol.45 (13), p.2304-2311

2009

Volltextzugriff (PDF)

Bacterial artificial chromosome-derived molecular markers for early bolting in sugar beet

Theoretical and applied genetics, 2005-04, Vol.110 (6), p.1027-1037

2005

Volltextzugriff (PDF)

Silver nanoparticles as a therapeutic agent in experimental cyclosporiasis

Experimental parasitology, 2019-12, Vol.207, p.107772, Article 107772

2019

Volltextzugriff (PDF)

Alectinib versus Crizotinib in Untreated ALK-Positive Non–Small-Cell Lung Cancer

The New England journal of medicine, 2017-08, Vol.377 (9), p.829-838

2017

Volltextzugriff (PDF)

A new scope for orlistat: Effect of approved anti-obesity drug against experimental microsporidiosis

Medical mycology (Oxford), 2019-02, Vol.57 (2), p.181-195

2019

Volltextzugriff (PDF)

European Organization for Research and Treatment of Cancer (EORTC) 08957 Phase II Study of Topotecan in Combination with Cisplatin as Second-Line Treatment of Refractory and Sensitive Small Cell Lung Cancer

Clinical cancer research, 2003-01, Vol.9 (1), p.143-150

2003

Volltextzugriff (PDF)

Encephalitozoon intestinalis: A new target for auranofin in a mice model

Medical mycology (Oxford), 2020-08, Vol.58 (6), p.810-819

2020

Volltextzugriff (PDF)

Impact of relatively new chemotherapeutic agents on the outcome of Egyptian patients with advanced malignant pleural mesothelioma

Forum of clinical oncology, 2014-08, Vol.5 (1), p.29-36

2014

Volltextzugriff (PDF)

Randomized Phase III Study of Cisplatin With or Without Raltitrexed in Patients With Malignant Pleural Mesothelioma: An Intergroup Study of the European Organisation for Research and Treatment of Cancer Lung Cancer Group and the National Cancer Institute of Canada

Journal of clinical oncology, 2005-10, Vol.23 (28), p.6881-6889

2005

Volltextzugriff (PDF)

P-13 Current and expected future profile changes of gastric and pancreatic cancer patients at presentation

Annals of oncology, 2020-07, Vol.31, p.S93

2020

Volltextzugriff (PDF)

1 – 25 von 262

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(218)
Mit Volltextzugriff
(215)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Englisch
(258)
Japanisch
(18)
Spanisch
(4)
Deutsch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(155)
Life Sciences & Biomedicine
(135)
Humans
(90)
Male
(64)
Female
(54)
Animals
(53)
Adult
(42)
Middle Aged
(37)
Biological And Medical Sciences
(30)
Oncology
(29)
Medical Sciences
(26)
Adolescent
(23)
Aged
(21)
Child
(21)
Egypt
(18)
General & Internal Medicine
(14)
Veterinary Sciences
(14)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(13)
Medicine, General & Internal
(13)
Pharmacology. Drug Treatments
(13)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Trimodality therapy for malignant pleural mesothelioma: results from an EORTC phase II multicentre trial

Prophylactic antineoplastic activity of Toxoplasma gondii RH derived antigen against ehrlich solid carcinoma with evidence of shared antigens by comparative immunoblotting

Is a patient's self-reported health-related quality of life a prognostic factor for survival in non-small-cell lung cancer patients? A multivariate analysis of prognostic factors of EORTC study 08975

Real-world Treatment Patterns and Outcomes in Stage III Non-small Cell Lung Cancer: Middle East and Africa – KINDLE Study

Evaluation of ImmunoCard STAT test and ELISA versus light microscopy in diagnosis of giardiasis and cryptosporidiosis

Afatinib in chemotherapy pre-treated EGFR mutation-positive NSCLC

162P Molecular markers in advanced non small cell lung cancer patients receiving gemcitabine & cisplatin

Chitosan and silver nanoparticles: Promising anti-toxoplasma agents

Molecular marker analysis of heading date Hd1 locus in Egyptian rice varieties

Toxoplasma gondii-derived antigen modifies tumor microenvironment of Ehrlich solid carcinoma murine model and enhances immunotherapeutic activity of cyclophosphamide

Epidemic of mesothelioma in Egypt

Prognostic effect of drug resistance of glutathione-S-transferase in non small lung cancer

Effect of alginate nanoparticles on the immunogenicity of excretory-secretory antigens against acute toxoplasmosis in murine model

3099 Phase 3 trial (NGR015) of best investigator choice (BIC) with or without NGR-hTNF in previously treated malignant pleural mesothelioma (MPM)

Evaluation of enzyme immunoassay techniques for diagnosis of the most common intestinal protozoa in fecal samples

A prognostic index for progression-free survival in malignant mesothelioma with application to the design of phase II trials: A combined analysis of 10 EORTC trials

Bacterial artificial chromosome-derived molecular markers for early bolting in sugar beet

Silver nanoparticles as a therapeutic agent in experimental cyclosporiasis

Alectinib versus Crizotinib in Untreated ALK-Positive Non–Small-Cell Lung Cancer

A new scope for orlistat: Effect of approved anti-obesity drug against experimental microsporidiosis

European Organization for Research and Treatment of Cancer (EORTC) 08957 Phase II Study of Topotecan in Combination with Cisplatin as Second-Line Treatment of Refractory and Sensitive Small Cell Lung Cancer

Encephalitozoon intestinalis: A new target for auranofin in a mice model

Impact of relatively new chemotherapeutic agents on the outcome of Egyptian patients with advanced malignant pleural mesothelioma

Randomized Phase III Study of Cisplatin With or Without Raltitrexed in Patients With Malignant Pleural Mesothelioma: An Intergroup Study of the European Organisation for Research and Treatment of Cancer Lung Cancer Group and the National Cancer Institute of Canada

P-13 Current and expected future profile changes of gastric and pancreatic cancer patients at presentation

Suchergebnisse filtern